187 related articles for article (PubMed ID: 23135838)
1. Investigation of the substrate range of CYP199A4: modification of the partition between hydroxylation and desaturation activities by substrate and protein engineering.
Bell SG; Zhou R; Yang W; Tan AB; Gentleman AS; Wong LL; Zhou W
Chemistry; 2012 Dec; 18(52):16677-88. PubMed ID: 23135838
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of CYP199A2, a para-substituted benzoic acid oxidizing cytochrome P450 from Rhodopseudomonas palustris.
Bell SG; Xu F; Forward I; Bartlam M; Rao Z; Wong LL
J Mol Biol; 2008 Nov; 383(3):561-74. PubMed ID: 18762195
[TBL] [Abstract][Full Text] [Related]
3. The importance of the benzoic acid carboxylate moiety for substrate recognition by CYP199A4 from Rhodopseudomonas palustris HaA2.
Coleman T; Chao RR; De Voss JJ; Bell SG
Biochim Biophys Acta; 2016 Jun; 1864(6):667-675. PubMed ID: 26969786
[TBL] [Abstract][Full Text] [Related]
4. The crystal structures of 4-methoxybenzoate bound CYP199A2 and CYP199A4: structural changes on substrate binding and the identification of an anion binding site.
Bell SG; Yang W; Tan AB; Zhou R; Johnson EO; Zhang A; Zhou W; Rao Z; Wong LL
Dalton Trans; 2012 Jul; 41(28):8703-14. PubMed ID: 22695988
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the requirements for efficient and selective cytochrome P450 monooxygenase catalysis across different reactions.
Podgorski MN; Coleman T; Chao RR; De Voss JJ; Bruning JB; Bell SG
J Inorg Biochem; 2020 Feb; 203():110913. PubMed ID: 31759265
[TBL] [Abstract][Full Text] [Related]
6. Selective oxidative demethylation of veratric acid to vanillic acid by CYP199A4 from Rhodopseudomonas palustris HaA2.
Bell SG; Tan AB; Johnson EO; Wong LL
Mol Biosyst; 2010 Jan; 6(1):206-14. PubMed ID: 20024082
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Factors which Result in Cytochrome P450 Catalyzed Desaturation Versus Hydroxylation.
Coleman T; Doherty DZ; Zhang T; Podgorski MN; Qiao R; Lee JHZ; Bruning JB; De Voss JJ; Zhou W; Bell SG
Chem Asian J; 2022 Dec; 17(24):e202200986. PubMed ID: 36268769
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450-catalyzed oxidation of halogen-containing substrates.
Coleman T; Podgorski MN; Doyle ML; Scaffidi-Muta JM; Campbell EC; Bruning JB; De Voss JJ; Bell SG
J Inorg Biochem; 2023 Jul; 244():112234. PubMed ID: 37116269
[TBL] [Abstract][Full Text] [Related]
9. Biophysical Techniques for Distinguishing Ligand Binding Modes in Cytochrome P450 Monooxygenases.
Podgorski MN; Harbort JS; Coleman T; Stok JE; Yorke JA; Wong LL; Bruning JB; Bernhardt PV; De Voss JJ; Harmer JR; Bell SG
Biochemistry; 2020 Mar; 59(9):1038-1050. PubMed ID: 32058707
[TBL] [Abstract][Full Text] [Related]
10. Enabling Aromatic Hydroxylation in a Cytochrome P450 Monooxygenase Enzyme through Protein Engineering.
Coleman T; Lee JZH; Kirk AM; Doherty DZ; Podgorski MN; Pinidiya DK; Bruning JB; De Voss JJ; Krenske EH; Bell SG
Chemistry; 2022 Dec; 28(67):e202201895. PubMed ID: 36043399
[TBL] [Abstract][Full Text] [Related]
11. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
12. The Stereoselective Oxidation of para-Substituted Benzenes by a Cytochrome P450 Biocatalyst.
Chao RR; Lau IC; Coleman T; Churchman LR; Child SA; Lee JHZ; Bruning JB; De Voss JJ; Bell SG
Chemistry; 2021 Oct; 27(59):14765-14777. PubMed ID: 34350662
[TBL] [Abstract][Full Text] [Related]
13. Regioselective oxidation of indole- and quinolinecarboxylic acids by cytochrome P450 CYP199A2.
Furuya T; Kino K
Appl Microbiol Biotechnol; 2010 Feb; 85(6):1861-8. PubMed ID: 20112454
[TBL] [Abstract][Full Text] [Related]
14. Design of H2O2-dependent oxidation catalyzed by hemoproteins.
Shoji O; Watanabe Y
Metallomics; 2011 Apr; 3(4):379-88. PubMed ID: 21308129
[TBL] [Abstract][Full Text] [Related]
15. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
16. Hoodwinking Cytochrome P450BM3 into Hydroxylating Non-Native Substrates by Exploiting Its Substrate Misrecognition.
Shoji O; Aiba Y; Watanabe Y
Acc Chem Res; 2019 Apr; 52(4):925-934. PubMed ID: 30888147
[TBL] [Abstract][Full Text] [Related]
17. Oxygen activation by cytochrome P450BM-3: effects of mutating an active site acidic residue.
Yeom H; Sligar SG
Arch Biochem Biophys; 1997 Jan; 337(2):209-16. PubMed ID: 9016815
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of a ferredoxin reductase for the CYP199A2 system from Rhodopseudomonas palustris.
Xu F; Bell SG; Peng Y; Johnson EO; Bartlam M; Rao Z; Wong LL
Proteins; 2009 Dec; 77(4):867-80. PubMed ID: 19626710
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
[TBL] [Abstract][Full Text] [Related]
20. Structure of the quinoline N-hydroxylating cytochrome P450 RauA, an essential enzyme that confers antibiotic activity on aurachin alkaloids.
Yasutake Y; Kitagawa W; Hata M; Nishioka T; Ozaki T; Nishiyama M; Kuzuyama T; Tamura T
FEBS Lett; 2014 Jan; 588(1):105-10. PubMed ID: 24269679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
